drugset / Trial / NCT00236860

A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures

NCT00236860

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of topiramate as add-on therapy in epilepsy patients with difficult to treat, partial-onset seizures who are taking one or two standard anti-epileptic drugs.

Timeline

Start
1989-05
Primary completion
Completion
1992-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 400 mg Oral

Indications